Curation tag: Community: CPTAC
From WikiPathways
The table below shows all 99 pathways that are tagged with curation tag: Community: CPTAC.
| Pathway name | Organism | Tagged by | Date tagged | Applies to latest revision |
|---|---|---|---|---|
| Apoptosis | Homo sapiens | Khanspers | 2022061420271320:27, 14 June 2022 | 2024012713562013:56, 27 January 2024 |
| G1 to S cell cycle control | Homo sapiens | Khanspers | 2022061420175620:17, 14 June 2022 | 2022072306473706:47, 23 July 2022 |
| Cell cycle | Homo sapiens | Susan | 2023091013325613:32, 10 September 2023 | 2025022722555322:55, 27 February 2025 |
| Cytokines and inflammatory response | Homo sapiens | Eweitz | 2024031612104012:10, 16 March 2024 | 2025022723032823:03, 27 February 2025 |
| Notch signaling | Homo sapiens | Elisson nl | 2023042323495723:49, 23 April 2023 | 2024011023012423:01, 10 January 2024 |
| Glycolysis and gluconeogenesis | Homo sapiens | Elisson nl | 2024021217004117:00, 12 February 2024 | 2025022723010223:01, 27 February 2025 |
| IL1 signaling | Homo sapiens | Khanspers | 2022061420340920:34, 14 June 2022 | 2023041915594015:59, 19 April 2023 |
| IL6 signaling | Homo sapiens | Eweitz | 2024052200403200:40, 22 May 2024 | 2024072719583119:58, 27 July 2024 |
| Integrin-mediated cell adhesion | Homo sapiens | Khanspers | 2022061420214720:21, 14 June 2022 | 2023041915552715:55, 19 April 2023 |
| MAPK signaling | Homo sapiens | Elisson nl | 2023042323233323:23, 23 April 2023 | 2024052200450300:45, 22 May 2024 |
| Notch signaling | Homo sapiens | Elisson nl | 2023042323134923:13, 23 April 2023 | 2025022723102123:10, 27 February 2025 |
| Hepatocyte growth factor receptor signaling | Homo sapiens | Khanspers | 2022061420163920:16, 14 June 2022 | 2024080612515112:51, 6 August 2024 |
| TGF-beta receptor signaling | Homo sapiens | DeSl | 2026013016405716:40, 30 January 2026 | yes |
| Wnt signaling | Homo sapiens | Khanspers | 2022061420242720:24, 14 June 2022 | 2023082600293500:29, 26 August 2023 |
| One-carbon metabolism | Homo sapiens | AlexanderPico | 2023080322421422:42, 3 August 2023 | 2024022102201002:20, 21 February 2024 |
| Non-homologous end joining | Homo sapiens | Khanspers | 2025020101433601:43, 1 February 2025 | 2025030113344013:34, 1 March 2025 |
| DNA mismatch repair | Homo sapiens | DeSl | 2025110616310316:31, 6 November 2025 | yes |
| Fatty acid beta-oxidation | Homo sapiens | Khanspers | 2022061420290020:29, 14 June 2022 | 2022123122505022:50, 31 December 2022 |
| Wnt signaling, NetPath | Homo sapiens | Elisson nl | 2025042519492619:49, 25 April 2025 | yes |
| Irinotecan pathway | Homo sapiens | Susan | 2022090513320413:32, 5 September 2022 | 2024013000372000:37, 30 January 2024 |
| Transcriptional activation by NRF2 in response to phytochemicals | Homo sapiens | Susan | 2023091013350613:35, 10 September 2023 | 2025022623453923:45, 26 February 2025 |
| EPO receptor signaling | Homo sapiens | Khanspers | 2025022619441319:44, 26 February 2025 | 2025030921411421:41, 9 March 2025 |
| Interferon type I signaling | Homo sapiens | Khanspers | 2022061419523619:52, 14 June 2022 | 2023041805515905:51, 18 April 2023 |
| Senescence and autophagy in cancer | Homo sapiens | Khanspers | 2022061505125705:12, 15 June 2022 | 2025041711253011:25, 17 April 2025 |
| Type II interferon signaling | Homo sapiens | Khanspers | 2022061420351620:35, 14 June 2022 | 2024072120373620:37, 21 July 2024 |
| ErbB signaling | Homo sapiens | Elisson nl | 2023042323510523:51, 23 April 2023 | 2023082600194500:19, 26 August 2023 |
| Methylation pathways | Homo sapiens | Khanspers | 2022061420500120:50, 14 June 2022 | 2025022723181923:18, 27 February 2025 |
| DNA damage response | Homo sapiens | DeSl | 2025110616314616:31, 6 November 2025 | yes |
| DNA damage response (only ATM dependent) | Homo sapiens | DeSl | 2025110616312316:31, 6 November 2025 | yes |
| Target of rapamycin signaling | Homo sapiens | Elisson nl | 2023042323051323:05, 23 April 2023 | 2025022723070623:07, 27 February 2025 |
| Angiogenesis | Homo sapiens | Elisson nl | 2024021216074316:07, 12 February 2024 | 2025022722580422:58, 27 February 2025 |
| Fluoropyrimidine activity | Homo sapiens | Khanspers | 2022061420371420:37, 14 June 2022 | 2023042517572217:57, 25 April 2023 |
| TP53 network | Homo sapiens | Khanspers | 2022061420273520:27, 14 June 2022 | 2023042619231919:23, 26 April 2023 |
| Retinoblastoma gene in cancer | Homo sapiens | Khanspers | 2022061420173320:17, 14 June 2022 | 2025022413092213:09, 24 February 2025 |
| ATM signaling | Homo sapiens | Elisson nl | 2025042519591119:59, 25 April 2025 | 2025102911150911:15, 29 October 2025 |
| PDGF pathway | Homo sapiens | Susan | 2025100520455720:45, 5 October 2025 | yes |
| Bladder cancer | Homo sapiens | Susan | 2023091013341713:34, 10 September 2023 | 2024012719215719:21, 27 January 2024 |
| TCA cycle nutrient use and invasiveness of ovarian cancer | Homo sapiens | AlexanderPico | 2024021719584919:58, 17 February 2024 | 2025022413570813:57, 24 February 2025 |
| MFAP5-mediated ovarian cancer cell motility and invasiveness | Homo sapiens | Khanspers | 2022061419544119:54, 14 June 2022 | 2023071419271919:27, 14 July 2023 |
| MicroRNA for targeting cancer growth and vascularization in glioblastoma | Homo sapiens | Mkutmon | 2024032613551213:55, 26 March 2024 | 2025030122575422:57, 1 March 2025 |
| Photodynamic therapy-induced HIF-1 survival signaling | Homo sapiens | Khanspers | 2022061420363620:36, 14 June 2022 | 2025022503030203:03, 25 February 2025 |
| Photodynamic therapy-induced NF-kB survival signaling | Homo sapiens | Khanspers | 2022061420364720:36, 14 June 2022 | 2024022103113003:11, 21 February 2024 |
| Imatinib and chronic myeloid leukemia | Homo sapiens | Khanspers | 2022061420362020:36, 14 June 2022 | 2024072719284219:28, 27 July 2024 |
| Hepatitis C and hepatocellular carcinoma | Homo sapiens | Khanspers | 2022061505134505:13, 15 June 2022 | 2024013000162800:16, 30 January 2024 |
| Wnt/beta-catenin signaling in leukemia | Homo sapiens | Khanspers | 2022061420231120:23, 14 June 2022 | 2024052200491500:49, 22 May 2024 |
| Regulation of Wnt / B-catenin signaling by small molecule compounds | Homo sapiens | Khanspers | 2022061420241220:24, 14 June 2022 | 2025022723123323:12, 27 February 2025 |
| lncRNA-mediated mechanisms of therapeutic resistance | Homo sapiens | Khanspers | 2022061420360820:36, 14 June 2022 | 2022072306242406:24, 23 July 2022 |
| PI3K-AKT-mTOR signaling and therapeutic opportunities in prostate cancer | Homo sapiens | Mkutmon | 2024032613585513:58, 26 March 2024 | 2024051015515315:51, 10 May 2024 |
| TGF-beta signaling in thyroid cells for epithelial-mesenchymal transition | Homo sapiens | Elisson nl | 2024021216474116:47, 12 February 2024 | 2025022723134623:13, 27 February 2025 |
| ATR signaling | Homo sapiens | Khanspers | 2022061420302720:30, 14 June 2022 | 2024011719475619:47, 17 January 2024 |
| ATM signaling in development and disease | Homo sapiens | Khanspers | 2022061420300120:30, 14 June 2022 | 2022072306265906:26, 23 July 2022 |
| 4-hydroxytamoxifen, dexamethasone, and retinoic acids regulation of p27 expression | Homo sapiens | Khanspers | 2022061420365820:36, 14 June 2022 | 2022072306271706:27, 23 July 2022 |
| VEGFA-VEGFR2 signaling | Homo sapiens | Elisson nl | 2023042323124023:12, 23 April 2023 | yes |
| Chemokine signaling | Homo sapiens | Khanspers | 2022061420330420:33, 14 June 2022 | 2024052201300601:30, 22 May 2024 |
| Focal adhesion: PI3K-Akt-mTOR-signaling | Homo sapiens | Khanspers | 2022061420494820:49, 14 June 2022 | 2022110412584112:58, 4 November 2022 |
| DNA IR-double strand breaks and cellular response via ATM | Homo sapiens | DeSl | 2025110617030217:03, 6 November 2025 | yes |
| H19, Rb-E2F1, and CDK-beta-catenin in colorectal cancer | Homo sapiens | Elisson nl | 2024051318214518:21, 13 May 2024 | 2025022323021423:02, 23 February 2025 |
| miRNA regulation of p53 pathway in prostate cancer | Homo sapiens | Khanspers | 2022061420272320:27, 14 June 2022 | 2024022104502704:50, 21 February 2024 |
| DNA IR-damage and cellular response via ATR | Homo sapiens | DeSl | 2025110617075917:07, 6 November 2025 | yes |
| Clear cell renal cell carcinoma pathways | Homo sapiens | Khanspers | 2021061523112723:11, 15 June 2021 | 2022072306423906:42, 23 July 2022 |
| Endometrial cancer | Homo sapiens | Egonw | 2022071710413310:41, 17 July 2022 | 2023080922074322:07, 9 August 2023 |
| Tumor suppressor activity of SMARCB1 | Homo sapiens | Khanspers | 2025012923373423:37, 29 January 2025 | 2025022420454120:45, 24 February 2025 |
| Chromosomal and microsatellite instability in colorectal cancer | Homo sapiens | Khanspers | 2022061419533819:53, 14 June 2022 | 2022071805045505:04, 18 July 2022 |
| Ras signaling | Homo sapiens | Khanspers | 2022061420162020:16, 14 June 2022 | 2023092919532719:53, 29 September 2023 |
| Epithelial to mesenchymal transition in colorectal cancer | Homo sapiens | Khanspers | 2023082600161400:16, 26 August 2023 | 2023092018253918:25, 20 September 2023 |
| Regulation of sister chromatid separation at the metaphase-anaphase transition | Homo sapiens | Khanspers | 2021061523104123:10, 15 June 2021 | 2023082817381217:38, 28 August 2023 |
| Type 2 papillary renal cell carcinoma | Homo sapiens | Fehrhart | 2022080414151014:15, 4 August 2022 | 2024022104424704:42, 21 February 2024 |
| Hedgehog signaling | Homo sapiens | Fehrhart | 2024082811415411:41, 28 August 2024 | 2025022723083223:08, 27 February 2025 |
| Non-small cell lung cancer | Homo sapiens | Egonw | 2022071710423910:42, 17 July 2022 | 2023082520183720:18, 25 August 2023 |
| lncRNA in canonical Wnt signaling and colorectal cancer | Homo sapiens | Fehrhart | 2022080414144714:14, 4 August 2022 | 2023082600164500:16, 26 August 2023 |
| Breast cancer pathway | Homo sapiens | AlexanderPico | 2024021719591019:59, 17 February 2024 | 2025022622413522:41, 26 February 2025 |
| Pancreatic adenocarcinoma pathway | Homo sapiens | Khanspers | 2021061523100223:10, 15 June 2021 | 2022072306440506:44, 23 July 2022 |
| Ultraconserved region 339 modulation of tumor suppressor microRNAs in cancer | Homo sapiens | Khanspers | 2022061420185320:18, 14 June 2022 | 2025030122501822:50, 1 March 2025 |
| Metabolic reprogramming in colon cancer | Homo sapiens | Khanspers | 2021061523093023:09, 15 June 2021 | 2024122014272914:27, 20 December 2024 |
| Inhibition of exosome biogenesis and secretion by manumycin A in CRPC cells | Homo sapiens | Khanspers | 2022061420374920:37, 14 June 2022 | 2024072712420512:42, 27 July 2024 |
| ncRNAs in Wnt signaling in hepatocellular carcinoma | Homo sapiens | Fehrhart | 2022080414004214:00, 4 August 2022 | 2023082600210100:21, 26 August 2023 |
| ncRNAs involved in STAT3 signaling in hepatocellular carcinoma | Homo sapiens | Khanspers | 2022061420252920:25, 14 June 2022 | 2024072710491310:49, 27 July 2024 |
| NRF2-ARE regulation | Homo sapiens | Khanspers | 2022061420373520:37, 14 June 2022 | 2023082818293818:29, 28 August 2023 |
| MSMP expression regulation in cancer cells and its pro-angiogenic role in ovarian tumors | Homo sapiens | Fehrhart | 2022080414115314:11, 4 August 2022 | 2024022103010803:01, 21 February 2024 |
| Altered glycosylation of MUC1 in tumor microenvironment | Homo sapiens | Eweitz | 2024031601252701:25, 16 March 2024 | 2025021812361112:36, 18 February 2025 |
| Hippo-Merlin signaling dysregulation | Homo sapiens | Khanspers | 2022061420171420:17, 14 June 2022 | 2023081719440319:44, 17 August 2023 |
| FBXL10 enhancement of MAP/ERK signaling in diffuse large B-cell lymphoma | Homo sapiens | Elisson nl | 2024051318274318:27, 13 May 2024 | 2024072521581921:58, 25 July 2024 |
| Interactions between immune cells and microRNAs in tumor microenvironment | Homo sapiens | Khanspers | 2022061420383020:38, 14 June 2022 | 2024072623295023:29, 26 July 2024 |
| MFAP5 effect on permeability and motility of endothelial cells via cytoskeleton rearrangement | Homo sapiens | Khanspers | 2022061420384220:38, 14 June 2022 | 2023120406254106:25, 4 December 2023 |
| Neural crest cell migration in cancer | Homo sapiens | Khanspers | 2022061420224120:22, 14 June 2022 | 2022091719434719:43, 17 September 2022 |
| Translation inhibitors in chronically activated PDGFRA cells | Homo sapiens | Khanspers | 2022061420170320:17, 14 June 2022 | 2023082817454117:45, 28 August 2023 |
| Cancer immunotherapy by CTLA4 blockade | Homo sapiens | Fehrhart | 2022080414113914:11, 4 August 2022 | 2024012714420414:42, 27 January 2024 |
| Cancer immunotherapy by PD-1 blockade | Homo sapiens | Fehrhart | 2022080414113414:11, 4 August 2022 | 2023082520145520:14, 25 August 2023 |
| Measles virus infection | Homo sapiens | Fehrhart | 2022080414150414:15, 4 August 2022 | 2023080922091422:09, 9 August 2023 |
| Cytosolic DNA-sensing pathway | Homo sapiens | Fehrhart | 2022080414011714:01, 4 August 2022 | yes |
| Small cell lung cancer | Homo sapiens | NhungP | 2022112119374819:37, 21 November 2022 | 2023082520162620:16, 25 August 2023 |
| Hepatitis B infection | Homo sapiens | Elisson nl | 2024051318212418:21, 13 May 2024 | 2025022722002522:00, 27 February 2025 |
| Head and neck squamous cell carcinoma | Homo sapiens | Mkutmon | 2024032709252609:25, 27 March 2024 | 2025022721594721:59, 27 February 2025 |
| Melanoma | Homo sapiens | DeSl | 2025110609591909:59, 6 November 2025 | 2025110621570521:57, 6 November 2025 |
| Base excision repair | Homo sapiens | Khanspers | 2025020101393101:39, 1 February 2025 | 2025103111292111:29, 31 October 2025 |
| Nucleotide excision repair | Homo sapiens | Khanspers | 2025020101332801:33, 1 February 2025 | 2025021121305821:30, 11 February 2025 |
| EGFR tyrosine kinase inhibitor resistance | Homo sapiens | AlexanderPico | 2023080322425222:42, 3 August 2023 | 2023082817433817:43, 28 August 2023 |
| Direct reversal repair | Homo sapiens | Khanspers | 2025020101243801:24, 1 February 2025 | 2025111103083103:08, 11 November 2025 |
| CCL18 signaling | Homo sapiens | AlexanderPico | 2023043019301019:30, 30 April 2023 | 2024052200382300:38, 22 May 2024 |

